Literature DB >> 11518784

In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1.

Alan D Salama1, Afzal N Chaudhry1, James J Ryan1, Efram Eren2, Jeremy B Levy1, Charles D Pusey1, Liz Lightstone1, Robert I Lechler2.   

Abstract

Goodpasture's disease is characterized by rapidly progressive glomerulonephritis and pulmonary hemorrhage, in association with circulating and deposited anti-glomerular basement membrane antibodies that recognize the alpha3 chain of type IV collagen [alpha3(IV)NC1] (known as the Goodpasture antigen). Unlike many other autoimmune diseases, recurrences are rare. In experimental models and human studies, both humoral and cellular mechanisms have been demonstrated to be involved in disease pathogenesis. However, there are few data on the characteristics of the autoreactive T cells or the mechanisms of tolerance to the autoantigen in human patients. It was demonstrated, using immunohistochemical analyses and reverse transcription-PCR, that the Goodpasture antigen is expressed in normal human thymus. Using limiting dilution analyses, the frequencies of circulating autoreactive T cells in patients and control subjects were assessed. During acute disease, there were increased frequencies of CD4(+) T cells reactive with alpha3(IV)NC1 (ranging from 1:6300 to 1:65,000), which decreased with time. There was a significant difference between patients during their acute disease phase and control subjects with respect to the frequency index for alpha3(IV)NC1-specific CD4(+) T cells (P < 0.05, Mann Whitney U test). The decrease in autoreactive CD4(+) T-cell numbers during recovery may be the reason why recurrences are infrequent and may explain the loss of pathogenic autoantibodies with time, because of a lack of T-cell help.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518784     DOI: 10.1681/ASN.V1291908

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  17 in total

Review 1.  Basement membranes and autoimmune diseases.

Authors:  Mary H Foster
Journal:  Matrix Biol       Date:  2016-08-02       Impact factor: 11.583

Review 2.  Cutting edge issues in Goodpasture's disease.

Authors:  Andrew L Chan; Samuel Louie; Kevin O Leslie; Maya M Juarez; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

3.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

Review 4.  Advances in human antiglomerular basement membrane disease.

Authors:  Zhao Cui; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

5.  Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.

Authors:  Xiao-yu Jia; Zhao Cui; Rui Yang; Shui-yi Hu; Ming-hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-29       Impact factor: 8.237

Review 6.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

Review 7.  Mammalian collagen IV.

Authors:  Jamshid Khoshnoodi; Vadim Pedchenko; Billy G Hudson
Journal:  Microsc Res Tech       Date:  2008-05       Impact factor: 2.769

8.  Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN.

Authors:  Diana S Y Tan; Poh Y Gan; Kim M O'Sullivan; Maree V Hammett; Shaun A Summers; Joshua D Ooi; Brita A Lundgren; Richard L Boyd; Hamish S Scott; A Richard Kitching; Ann P Chidgey; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 10.121

9.  AKI in an HIV patient.

Authors:  P Matthew Hartle; Mariu E Carlo; Jamie P Dwyer; Agnes B Fogo
Journal:  J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 10.121

10.  Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen.

Authors:  Ying Zhang; Susan C Su; Douglas B Hecox; Graham F Brady; Katherine M Mackin; Amy G Clark; Mary H Foster
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.